Placenta is an association of fetal and maternal tissues which develops during pregnancy. Placenta is often called lifeline, because it is the link between mother and growing fetus. It serves variety of functions, which include transport of nutrients to growing fetus, waste products from fetus, exchange of gases and also immunological protection to the fetus. It has a unique ability to function as a hypothalamo-pituitary-gonadal-axis as it can produce a variety of peptide, protein and steroid hormones. Thus, it is an autonomous unit capable of regulating its own growth and function.
INTRODUCTION
Placenta is an association of fetal and maternal tissues which develops during pregnancy and is often called lifeline, because it is the link between mother and growing fetus. Placenta serves variety of functions, which include transport of nutrients to growing fetus, waste products from fetus, exchange of gases, providing immunological protection as the fetus is an allograft. The proper development and growth of placenta is of utmost importance and critical in the outcome of successful pregnancy. In fact, now it is accep ted that several adult diseases have fetal origin and maternal health influences the outcome of pregnancy and well being of fetus and new born. Poor nutrition, anemia, infec tions, etc. during pregnancy affect not only the health of pregnancy woman, but also the growth of the fetus. Several pregnancy related disorders, for example, Intra uterine growth retardation (IUGR), Pre-eclampsia, Spina bifida, etc. have their origin in nutritional deficiencies during pregnancy. Thus, the key link between the mother and fetus is placenta by providing adequate nutrition and other support such as providing oxygen, removal of waste products and hormonal support for growth and metabolism to the fetus.
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REGULATION OF GROWTH OF PLACENTA
It is interesting to note that placental growth occurs only during early pregnancy. Subsequently it grows only in size. It has been established that placental weight is related to the weight of the new born. Several factors influence the growth and function of placenta among which are nutri tional status of mother, level of estrogen, progesterone, gona dotropin releasing hormone (GnRH) and several other growth factors. Earlier studies from our laboratory have shown that estrogen plays an important role in regulation of growth and function of placenta in humans. We have shown that estrogen stimulates general as well as specific protein synthesis in placenta. 2 Considering the importance of the placenta in pregnancy, we have studied the regulation of growth of placenta using the molecular marker of growth namely Telomerase (TR). TR is a Ribonucleoprotein enzyme complex and functions to compensate for replicationassociated loss in telomeric repeats. Its activity correlated with cell immortalization. Most human tumors are TR 1 positive whereas somatic tissues are TR negative. In the human fetus, TR activity is detectable in many tissues early in gestation. During development, there is tissue-specific loss in TR activity. Human placenta is similar to many TR positive tumors and malignant tropho blastic diseases exhibit very high telomerase activity in the context of placenta. The normal villi have lower levels of TR activity and villi from cases of IUGR/preeclampsia show undetectable levels. Placenta resembles a tumor in terms of it invasive characteristics but unlike tumors, it is a well controlled invasion in placenta. 3 Placenta serves as a transient hypothalamopituitary axis by its ability to produce, proteins, peptides and ste roid hor mones. Of the several hormones produced by the pla centa steroid such as estrogen and progesterone are pro duced relatively in large quantities, during pregnancy. 4 Of these two hor mones namely, estrogen and progesterone, estrogen is a known mitogenic hormone and with the progress in preg nancy there is a rapid increase in the serum and placental levels of estrogens. This coincides with differen tiation of cytotrophoblasts into syncytiotrophoblasts. Our studies revealed that estrogen induces differentiation of cyto tro phoblasts in to syncytiotrophoblasts and interestingly as men tioned earlier there is significant increase in estrogen pro duction during the differentiation process. Differentiation process which could be induced by estrogen could be blocked by addition of ICI182780, an estrogen receptor anta gonist. It is known that cytotrophoblasts are highly proli fe rative and high in telomerase activity which is an indi cator of growth. As mentioned earlier TR activity dec reases during differentiation of cytotrophoblasts into syncytio trophoblasts.
In an attempt to elucidate the mediator of the estrogen indeed differentiation of cytotrophoblasts into syncytiotrophoblasts.
We analyzed the levels of TGFβ1 known for its role in cellular differentiation. Interestingly there was a significant increase in the expression of TGFβ1 both at the mRNA levels as assessed by RTPCR, as well as at protein level as assessed by Western blot analysis. In an attempt to establish the role of TGFβ1, we have further investigated the effect of addition of TFGβ1 on the TR activity. Interestingly, there was significant decrease in the TR activity along with differentiation of the cytotrophoblasts into syncytiotrophoblasts following addition of TGFβ1.
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REGULATION OF ENDOCRINE FUNCTION OF PLACENTA
As mentioned earlier the human placenta also serves as a very efficient endocrine gland by its ability to synthesize and secrete a variety of protein, peptide and steroid hormones.
In most of the primate species, not only the steroid hormone producing function of ovary but also the function of hypo thalamopituitary axis is taken over by the placenta. Human placenta produces protein hormones like chorionic gona do tropin (CG) and chorionic somatomammotropin similar to luteinizing hormone (LH) and growth hor mone (GH) res pectively, produced by the pituitary. The large quantities of progesterone and estrogens, which are produced by the ovary, are also produced by placenta. It has also been demons trated that several peptides like GnRH adrenocortico trophic hormone (ACTH) and relaxin, etc. are produced the placenta.
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Consi dering this, it is justified in suggesting that human placenta serves as a transient hypothalamopituitarygona dal axis during pregnancy. Although the regulatory inter relationship between hypothalmopituitary gondal axis has not been established in placenta. However, it is likely that the regu latory mechanism seen in the hypothalamopituitarygonadal axis could be operative in the placenta also. 4 It has been well established that pituitary LH is under the control of hypothalamic GnRH. Considering the fact that CG is very similar to LH both structurally and functionally, it is likely that CG may also be regulated by placental GnRH.
Our investigations demonstrating the presence of specific receptors for GnRH as demonstrated by the binding of 125 1
GnRH to human placental cell membranes support this assump tion. The presence of GnRH transcripts in human placenta has been demonstrated by northern analysis of the human placenta RNA.
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Although distinct signal corresponding to 1.8 kB was seen in human first trimester human placenta, the levels of GnRH transcript appears to be low in the term placenta. Additional evidence was provided by demonstrating the pre sence of GnRH receptor protein in the placental mem branes probed using a specific antiserum raised to the bonnet monkey pituitary GnRH receptor fragment. A signal corres ponding to approximate 70 kDa which corresponded to the size of rat pituitary GnRH receptor was observed. 12 Following this we examined in vitro effect of the addition of GnRH on CG levels. Increase in both immunoreactive CG level as well as synthesis of CG was noticed. Further inclusion of specific GnRH receptor antagonist prevented increase in the levels of CG. Furthermore, addition of Busserelin, an analog of GnRH resulted in an increase in immuno reactive mCG in the monkey placenta. Additional evidence to support the conclusion that GnRH stimulates the secretion of CG in human placenta was provided by studies indicating the involvement of Ca 2 ++ in mediating the GnRH stimulated CG secretion. 13, 14 The involvement of GnRH in regulation of CG under in vivo conditions was provided by demonstrating that acute or chronic administration of GnRH or Buserelin during early pregnancy in the bonnet monkey resulted in an increase in tile serum level of mCG. Also injection of antiserum GnRH caused a transient but immediate decrease in serum mCG levels. 15 To investigate the role of P4 and E2 in the regulation of CG synthesis, specific antagonists and inhibitors such as RU 486 and or Progesterone or aromatase inhibitor or tamo xifen (TMX) were added to both first trimester human placenta (FTHP) and term placental (TP) minces under in vitro conditions. It was found that while the secretion of CG is under negative modulation by E2 us judged by an increase in immunoreactive CG levels as well as mRNA levels specific for alpha and beta CG subunits, addition of RU486 or dexamethasone or P4 resulted in an increase in the levels of immunoreactive CG protein and transcripts. It was interesting to note that the addition of dexamethasone had differential effect, in that while a combination of RU486 and dexamethasone had an additive effect on CG mRNA levels, in FTHP no such effect was seen on hCG mRNA level. The negative modulation of synthesis of CG by E2 was seen even in the monkey placenta where in, addition of TMX resulted in an increase in immunoreactive CG level. Although, both TMX and RU486 are known to be estrogen and PR antagonists respectively, we believe they are acting as agonists in the human placenta. It is well known that these compounds can exert both agonistic and antagonist effects depending on the concentration, species, tissue and gene in question. 1618 Very little information is available on the possible factors involved in the regulation of P4 production by placenta. The capacity of placenta to synthesize cholesterol de novo from acetate is limited and all the cholesterol needed for P4 synthesis is obtained from maternal circulation in the form of low density lipoprotein (LDL) which is taken up by specific receptors on the placental membranes. The uptake of LDL by specific receptors is rate limiting in the biosynthesis of P4 in placenta. Also one of the earliest steps in the stimulation of adrenal steroids by ACTH or gonadal steroids by gonadotropin is up regulation of LDL receptor expression. Considering this, examined the effect of addition of hCG on LDL receptor expression in human placenta. Our results indicated that hCG up regulates LDL receptor expression in human placenta. In addition it was found that both E2 and P4 have a role in regulation of LDL receptor expression. 19 Although the human placenta is a discarded tissue at the end of pregnancy it serves as an excellent model to investi gate a variety of physiological and molecular mecha nisms operating in the placenta. As mentioned earlier, it is an excellent model to study the proliferation mechanisms opera ting in cancer cells. The endocrine function of the human placenta is unique in that it resembles the hypo thalamo pituitary axis. However, it should be noted that no neural mechanisms operate in the regulation of synthesis and secretion of variety of hormones. The human placental system consisting of cyto and syncytiotrophoblasts is an excellent model to investigate the autocrine and paracrine mechanism of regulation. It need not be emphasized that the fetus being an allograft the placenta is a unique tissue in selectively preventing the rejection of the growing fetus. Selective permeability is a unique property of human placenta and thus it is very evident that the human placental system can be employed as an excellent model to study regulation of transport, growth and differentiation.
